Combination Effect of Silver Nanoparticles and Histone Deacetylases Inhibitor in Human Alveolar Basal Epithelial Cells

Although many treatment strategies have been reported for lung disease, the mechanism of combination therapy using silver nanoparticles (AgNPs) and histone deacetylases inhibitors (HDACi) remains unclear. Therefore, innovative treatment strategies are essential for addressing the therapeutic challen...

Descripción completa

Detalles Bibliográficos
Autores principales: Gurunathan, Sangiliyandi, Kang, Min-hee, Kim, Jin-Hoi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222610/
https://www.ncbi.nlm.nih.gov/pubmed/30111752
http://dx.doi.org/10.3390/molecules23082046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222610/
https://www.ncbi.nlm.nih.gov/pubmed/30111752
http://dx.doi.org/10.3390/molecules23082046

Ejemplares similares